• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Keywords » prevention

Items Tagged with 'prevention'

ARTICLES

Research Update

A Promising Combo: Olanzapine and Samidorphan

July 1, 2024
Earth Hasassri, MD
From The Carlat Child Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Earth Hasassri, MD. Dr. Hasassri has no financial relationships with companies related to this material.

When we must use antipsychotics (NbN D2 receptor blockers), we do whatever we can to avoid side effects from them. This research upside looks at the potential for the new olanzapine-semiglutide combination medication to reduce D2 blocker-related weight gain in children and teens.


Read More
Expert Q&A

Understanding Suicide: Prevention and Intervention Strategies

April 1, 2024
J. John Mann, MD
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

CHPR_QA1_Suicide Prvtn_JJohnMann_photo.pngJ. John Mann, MD.

Paul Janssen Professor of Translational Neuroscience in Psychiatry and Radiology; Director, Molecular Imaging and Neuropathology Division; Co-Director, Columbia Center for Prevention and Treatment of Depression, Columbia University/New York State Psychiatric Institute, New York, NY.

Dr. Mann receives royalties from the Research Foundation for Mental Hygiene for the commercial use of the Columbia-Suicide Severity Rating Scale and royalties from Columbia University for the Columbia Psychiatry Pathways app. Relevant financial relationships listed for the author have been mitigated.

We examine effective suicide prevention techniques, highlighting simple yet impactful methods such as post-hospitalization follow-ups via phone calls or postcards. Dr. Mann offers insight into these and other interventions that have been successful in lowering suicide rates.


Read More
Clinical Update

How to Identify and Treat Prodromal Symptoms of Bipolar Disorder and Schizophrenia

September 1, 2023
José S. Sanchez-Cruz, MD
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

José S. Sanchez-Cruz, MD. Chief Resident, Department of Psychiatry, NYU Langone Health, New York. Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report; Assistant Professor, NYU Langone Department of Psychiatry; practicing psychiatrist, Winston-Salem, NC.

Dr. Sanchez-Cruz and Dr. Aiken have no financial relationships with companies related to this material.

Patients with genetic risks for schizophrenia and bipolar disorder often present with prodromal symptoms of the illness, but the most effective treatment may surprise some. It’s not a medication.


Read More
canstockphoto52138604.jpg

Readily Available and Easily Abused Over-the-Counter Medications

January 2, 2023
Joshua Feder, MD and Mara Goverman

Reviewing four commonly abused substances that are legally available for purchase: Dextromethorphan, antihistamines, pseudoephedrine, and Kratom.


Read More

Psychotherapy and Medication in Recurrent Depression

June 29, 2021
Giovanni Fava, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Giovanni Fava, MDGiovanni Fava, MD

Clinical Professor of Psychiatry at the State University of New York at Buffalo. Editor-in-Chief of the journal Psychotherapy and Psychosomatics and author of over 500 scientific papers. His book, Discontinuing Antidepressant Medications, is due from Oxford University Press in 2021. Dr. Fava has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Antidepressants treat depression, but patients need something more to prevent future episodes. Giovanni Fava describes an evidence-based method that blends medication with psychotherapy in two phases: sequential treatment for prevention of depression.
Read More

Stigmatizing Smoking: An Effective Deterrent?

March 30, 2020
Benjamin Oldfield, MD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Benjamin Oldfield, MD Dr. Oldfield has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
In a randomized controlled trial, researchers tested a statement that invokes shame in people who smoke cigarettes and measured how it impacts the time until they smoke the next cigarette.
Read More

Predicting and Preventing Fatal Opioid Overdoses

March 30, 2020
Kristen Gardner, PharmD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Kristen Gardner, PharmD Dr. Gardner has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
In addition to when we prescribe opioids, there are other opportunities and interactions patients have with the health care system upon which we can intervene to mitigate overdose risk. This study describes some of those opportunities, many of which happen every day in addiction clinics.
Read More

Harm Reduction Strategies—A Primer

February 11, 2020
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
To minimize harm and optimize safety among people who use drugs, particularly injections drugs, learn the nuts and bolts of naloxone distribution, syringe exchange, pre-exposure prophylaxis (PrEP) for HIV prevention, and fentanyl testing.
Read More
EXPERT Q&A

The Clinician’s Role: Reducing Harm Among People Who Use Drugs

February 11, 2020
Kimberly Sue, MD, PhD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information

Kimberly Sue, MD, PhD
Medical Director of the Harm Reduction Coalition (www.harmreduction.org). Attending physician at Rikers Island Correctional Health Services, NY. Dr. Sue has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Addiction researcher and medical director of the Harm Reduction Coalition shares her approach to patients and provides state-specific resources for clinicians interested in connecting with harm reduction resources locally.
Read More

How to Talk to Patients About the Risk of Opioid Overdose

February 11, 2020
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
How do you engage patients in discussion surrounding overdose risk? Learn some evidence-based strategies that will build trust, be accessible and understandable to patients, and empower them to use as safely as possible.
Read More
More Articles Tagged with 'prevention'
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2622607431.jpg
    General Psychiatry

    Should You Test MTHFR?

    MTHFR is a...
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.